Xianju Pharmaceutical announced that the company previously reviewed and approved the repurchase plan. It plans to use 80 million yuan to 150 million yuan to repurchase shares. The upper limit of the repurchase price will be adjusted from 13.45 yuan/share to 13.25 yuan/share for equity incentives or employee stock ownership plans. As of the announcement date, the company had repurchased a total of 17.953 million shares, accounting for 1.8149% of the total share capital, the highest transaction price was 8.71 yuan/share, the lowest transaction price was 7.92 yuan/share, and the total capital used was 150 million yuan. The implementation of this repurchase plan was completed.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.